Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Eradication Therapy on Helicobacter Pylori Infection in Patients With COPD
NCT07574879Phase 1Recruiting
- Sponsor
- Zagazig University
- Start
- Mar 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Helicobacter pylori infection, sponsored by Zagazig University. Primary endpoint: Primary outcome measures at 3 months. Started Mar 2026; status: recruiting.
02
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07574879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07574879.